CasNo.475102-14-8,N-BOC-5-methylindole-2-boronic acid,(475102-14-8) Suppliers

1 Kilogram	Negotiable

Min.Order :1 Kilogram
Purity: ≥ 99.0%
Payment Terms : L/C,D/A,D/P,T/T,Other

Keywords

5-Methyl-1H-indole-2-boronic acid, N-Boc-5-Methyl-1H-indol-2-yl boronic acid 1-BOC-5-METHYL-1H-INDOLE-2-BORONIC ACID

Quick Details

Appearance:White Powder
Application:pharmaceutical intermediate
PackAge:NW 1kg/foil bag; 20-25kg/drum or carton
ProductionCapacity:20|Metric Ton|Month
Storage:Stored in a dark, cool, ventilated and dry place
Transportation:by air/sea/express,according to request.

Superiority:

Description & Specification

Category	Pharmaceutical Raw Materials, Fine Chemicals, Bulk drug
Standard	Medical standard
Shelf life	2 years
Storage	should be stored in a well-closed container at low temperature, keep away from moisture, heat and light.
Test Item	Standard: USP
Identification	IR spectrum similar to that of RS
Identification	HPLC retention time similar to that of RS
Related substance	Total impurities: NMT0.3%
Related substance	Single impurity: NMT0.1%
Heavy metals	NMT 10ppm
Loss on drying	NMT0.5%
Residue on ignition	NMT0.1%
Assay	98.5%-101.0%

Details:

Wuhan BJM Pharm Inc. was found in 2013, located in Hubei Province, where has long history, rich culture, convenient traffic, beautiful environment and preferential policy.

We have two factories in Dezhou , Shandong and Xianning, Hubei. The factory covers an area of 48,000 square meters with the building area of 26,000 square meters. We are specialized in the manufacture of pharmaceutical intermediates and cosmetic additives with good inspection equipments and innovative R & D capability.

In 2006, We established Lingxian Microworld Chemical New Material Co,.Ltd.

In 2008, We passed ISO quality system certificate

In 2013, We established Wuhan Benjamin Pharmaceutical Chemical Co.,Ltd , and obtain self-operation Import & Export right, mainly responsible for domestic and foreign business. At the same time, we set up R&D lab in Wuhan,Hubei province, can undertake various custom synthesis of intermediates and APIs.

In 2016, obtain a registered trademark “ BJM ”.

In 2017, we applied for the invention patent of TRIS, and in 2018, we applied for the invention patent of ERDOSTAN intermediate（DL-HOMO）. At present, we have6 patents passed the preliminary examination, and 4 patents are under examination and approval.

In 2019, we purchased a R&D and office building with a total area of 2500 square meters, as our headquarters in Wuhan.

In 2020, we registered BJM Pharm Yunmeng Co., Ltd, and the new production base settled in Geputan chemical park with a total area of 50000 square meters.

We stick to the principle as: people-oriented, customer first, Hope to establish a win-win business relationship with all friends.